- decreased body weight / MGI
- decreased white adipose tissue amount / MGI
- hepatic steatosis / MGI
- decreased circulating triglyceride level / MGI
- abnormal white adipose tissue morphology / MGI
- increased liver weight / MGI
- decreased circulating cholesterol level / MGI
- abnormal metabolism / MGI
- decreased oxygen consumption / MGI
- decreased heart rate / MGI
- abnormal mitochondrion morphology / MGI
- increased white fat cell size / MGI
- decreased gonadal fat pad weight / MGI
B6.129-Ppargc1btm1.1Avp/Kctt
Status | Available to order |
EMMA ID | EM:04679 |
International strain name | B6.129-Ppargc1btm1.1Avp/Kctt |
Alternative name | B6.129-Ppargc1b tm1AZTC |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Ppargc1btm1.1Avp, |
Gene/Transgene symbol | Ppargc1b |
Information from provider
Provider | Mohammad Bohlooly |
Provider affiliation | ATCG, AstraZeneca R&D |
Genetic information | A triple loxP strategy was used to target the PGC-1b (Ppargc1b) locus to generate mice with both standard and conditional knock-out alleles at this locus. The homology region used in the targeting vector was amplified by proof-reading PCR using a 129/SvJ genomic RPCI Mouse PAC clone as a template. In essence, the targeting vector was a ~8kb 129/SvJ mouse genomic subclone containing a floxed neomycin phosphotransferase selectable marker cassette inserted into intron 3 and a single loxP site inserted into intron 5. |
Phenotypic information | PGC-1beta (Ppargc1b) knock-out mice are generally viable and metabolically healthy. Using systems biology, we identified a general defect in the expression of genes involved in mitochondrial function and, specifically, the electron transport chain. This defect correlated with reduced mitochondrial volume fraction in soleus muscle and heart, but not brown adipose tissue (BAT). Under ambient temperature conditions, PGC-1beta ablation was partially compensated by up-regulation of PGC-1alpha in BAT and white adipose tissue (WAT) that led to increased thermogenesis, reduced body weight, and reduced fat mass. Despite their decreased fat mass, PGC-1beta knock-out mice had hypertrophic adipocytes in WAT. The thermogenic role of PGC-1beta was identified in thermoneutral and cold-adapted conditions by inadequate responses to norepinephrine injection. Furthermore, PGC-1beta knock-out hearts showed a blunted chronotropic response to dobutamine stimulation, and isolated soleus muscle fibres from PGC-1beta knock-out mice have impaired mitochondrial function. Lack of PGC-1beta also impaired hepatic lipid metabolism in response to acute high fat dietary loads, resulting in hepatic steatosis and reduced lipoprotein-associated triglyceride and cholesterol content. Altogether, our data suggest that PGC-1beta plays a general role in controlling basal mitochondrial function and also participates in tissue-specific adaptive responses. |
Breeding history | The strain is bred on C57BL/6 in a het x wt colony. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Disease and phenotype information
MGI phenotypes (allele matching)
Literature references
- PGC-1beta: a co-activator that sets the tone for both basal and stress-stimulated mitochondrial activity.;Lelliott Christopher J, Vidal-Puig Antonio, ;2009;Advances in experimental medicine and biology;646;133-9; 19536672
- Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.;Lelliott Christopher J, Medina-Gomez Gema, Petrovic Natasa, Kis Adrienn, Feldmann Helena M, Bjursell Mikael, Parker Nadeene, Curtis Keira, Campbell Mark, Hu Ping, Zhang Dongfang, Litwin Sheldon E, Zaha Vlad G, Fountain Kimberly T, Boudina Sihem, Jimenez-Linan Mercedes, Blount Margaret, Lopez Miguel, Meirhaeghe Aline, Bohlooly-Y Mohammad, Storlien Leonard, Strömstedt Maria, Snaith Michael, Oresic Matej, Abel E Dale, Cannon Barbara, Vidal-Puig Antonio, ;2006;PLoS biology;4;e369; 17090215
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).